Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone

Giveon, S; Zacay, G; Vered, I; Foldes, AJ; Tripto-Shkolnik, L

Giveon, S (通讯作者)，Sheba Med Ctr, Div Endocrinol Diabet & Metab, Sheba Rd 2, IL-5262100 Ramat Gan, Tel Hashomer, Israel.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2023; 14 ():

Abstract

Background: Teriparatide (TPTD) should be followed by an antiresorptive to maximize bone mineral density gain and anti-fracture protection. Infrequent......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索